FDA Adverse Event Injury Summary report: N

ALTRUA

MDR report key: 3210197 · Received July 8, 2013

Report

Report Number
2124215-2013-08499
Event Type
Injury
Date Received
July 8, 2013
Date of Event
April 19, 2013
Report Date
May 31, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
NVZ
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT HAS BEEN RECEIVED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. A VISUAL INSPECTION OF THE DEVICE HEADER AND CASE NOTED NO ANOMALIES. PIN GAUGE TESTING, DESIGNED TO VERIFY PROPER PORT DIMENSIONS, WAS COMPLETED. EACH PORT MEASURED AS EXPECTED. THE DEVICE WAS THEN EXPOSED TO SIMULATED HEART LOAD CONDITIONS, AND THE PACING AND SENSING FUNCTIONS WERE TESTED. THE DEVICE OPERATED APPROPRIATELY, ACCORDING TO ITS PERFORMANCE SPECIFICATIONS, WITH NO INTERRUPTIONS IN THERAPY OUTPUT OR PROGRAMMER COMMUNICATION AT THE RETURNED PROGRAMMED SETTINGS. A SERIES OF ELECTRICAL TESTS WAS ALSO PERFORMED, AND AGAIN, NORMAL DEVICE FUNCTION WAS OBSERVED.

Description of Event or Problem · 1

--

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS PACEMAKER AND RIGHT VENTRICULAR (RV) LEAD WAS SYMPTOMATIC DUE TO INTERMITTENT EXIT BLOCK. THE CAUSE OF THE EXIT BLOCK WAS UNABLE TO BE DETERMINED. PACING INHIBITION WAS OBSERVED AND AN INCREASE IN PACING THRESHOLD MEASUREMENTS WAS NOTED. AN INVASIVE PROCEDURE WAS PERFORMED. THIS DEVICE WAS SUCCESSFULLY EXPLANTED AND THE RV LEAD WAS SURGICALLY ABANDONED. A NEW SYSTEM WAS IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
310003 ALTRUA IMPLANTABLE PULSE GENERATOR NVZ GUIDANT CRM CLONMEL IRELAND S603

Patients

Seq Age Sex Outcome Treatment
1 53 YR Hospitalization| L| R 4469| 1290| 4087| S603